Status:
UNKNOWN
The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Fertility Disorders
Thyroid Dysfunction
Eligibility:
FEMALE
18-36 years
Phase:
NA
Brief Summary
The influence of thyroid autoantibodies on thyroid function in pregnancy after fertility treatment is not well known. The objectives of the present study are: 1. To monitor the course of thyroid fun...
Detailed Description
Thyroid autoantibodies and / or abnormal thyroid function are associated with fertility problems. A possible explanation for this is, an influence of thyroid autoantibodies on the functioning of the ...
Eligibility Criteria
Inclusion
- first cycle of assisted reproductive technology with follow up of thyroid function at the Universitair Ziekenhuis Brussel
- age \>= 18 and \<= 36 years
- body mass index between 18 and 35
Exclusion
- Patients with clinical thyroid dysfunction
- Patients being treated with levothyroxine or antithyroid drugs
- Patients being treated with glucocorticosteroids
- Patients undergoing in vitro maturation or preimplantation genetic testing.
- Poor responders during IVF/ICSI stimulation, using the Bologna criteria
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04019509
Start Date
January 1 2019
End Date
September 1 2022
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Brussels, Belgium, 1090